Non-Psychoactive Cannabinoid Composition for Sleep and Pain Relief

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for sleeplessness, anxiety, and pain often come with side effects such as addiction, hangovers, or ineffectiveness, and do not adequately address inflammation, leading to a need for non-addictive and effective solutions.

Innovation Solution

A composition comprising pharmacologically active, non-psychoactive cannabinoids, amino acid-based ingredients, receptor modulators, and extracts from medicinal plants, tree bark, or roots, administered in a form that is free from prescription drugs and psychoactive substances, providing a carrier or matrix for easy administration.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If prescription sleep medicines are used, then sleep quality is improved, but addiction and side effects occur

Engineering Contradiction:
Improvesleep qualityVSAvoidaddiction and side effects
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent changes the chemical parameters by using natural compounds (melatonin, valerian root, chamomile, magnesium) instead of prescription medications, altering the substance composition to eliminate addictive properties while maintaining sleep quality improvement

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent combines multiple natural ingredients (melatonin, valerian root extract, chamomile extract, magnesium) into a composite formulation that works synergistically to improve sleep without the harmful side effects of prescription drugs

Inventive Principle:
Principle #40Composite materials

2Ease of operation

If non-prescription sleep aids are used, then accessibility is improved, but effectiveness is reduced

Engineering Contradiction:
ImproveaccessibilityVSAvoideffectiveness
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent creates a composite formulation combining multiple proven natural sleep aids (melatonin, valerian root, chamomile, magnesium) to enhance effectiveness while maintaining over-the-counter accessibility without requiring a prescription

Inventive Principle:
Principle #40Composite materials

3Device complexity

If single-ingredient treatments are used, then simplicity is improved, but comprehensive treatment is reduced

Engineering Contradiction:
Improvetreatment simplicityVSAvoidcomprehensive treatment
Core Design Contradiction:
Device complexityVSAdaptability or versatility

Solution Approach 1:

The patent creates a multi-functional composition where a single product addresses multiple health issues simultaneously: sleep quality, anxiety, pain, and inflammation, making one comprehensive treatment that replaces multiple single-ingredient solutions

Inventive Principle:
Principle #6Universality (Multi-functionality)

4Reliability

If psychoactive cannabinoids are used, then pain relief is improved, but psychoactive effects occur

Engineering Contradiction:
Improvepain reliefVSAvoidpsychoactive effects
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent extracts and isolates the non-psychoactive cannabidiol (CBD) component from cannabis while deliberately excluding the psychoactive tetrahydrocannabinol (THC), achieving pain relief without unwanted psychoactive effects

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent changes the chemical composition parameters by using CBD with THC-free or trace amounts (less than 0.3%), altering the psychoactive profile while maintaining therapeutic pain relief benefits

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS20230056488A1Composition, article and method for affecting a mammal
Publication Date: 2023.02.23 COOLHOUSE SOURCING LLC
  • US20230056488A1 patent drawing
  • US20230056488A1 patent drawing
  • US20230056488A1 patent drawing

AI summary

Compositions, articles and methods for treating sleeplessness, anxiety, pain or inflammation include: (i) one or more pharmacologically active, non-psychoactive cannabinoids; (ii) one or more active agents; and an optional carrier or matrix. The optional carrier or matrix may comprise ingredients such as solvents, solid or dissolvable supports, fillers, flavorants, flavor or taste masking agents, and other adjuvants that provide the composition in a useful form factor configured for easy administration to a mammal of an appropriate pharmacological dosage of the active ingredients.